AVITA Medical Ltd. 近日披露了其Cohealyx®研究的中期分析数据,结果显示该疗法能够有效加速患者接受皮肤移植的进程。这一突破性进展为严重烧伤及创伤患者的临床治疗提供了新的优化路径。
AVITA Medical Ltd. 近日披露了其Cohealyx®研究的中期分析数据,结果显示该疗法能够有效加速患者接受皮肤移植的进程。这一突破性进展为严重烧伤及创伤患者的临床治疗提供了新的优化路径。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.